NAV
$87.78
AUM
$127.3M
Expense Ratio
-
Dividend Yield
0.06%
Beta
1.25
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +0.56% | +9.77% | +13.42% | +10.98% | -3.28% | -7.34% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | STAA | Staar Surgical Co | 2.95% |
| 2 | NVCR | NovoCure Ltd | 2.36% |
| 3 | IART | Integra Lifesciences Holdings Corp | 2.15% |
| 4 | AXGN | Axogen Inc | 2.13% |
| 5 | AVNS | Avanos Medical Inc | 2.10% |
| 6 | LNTH | Lantheus Holdings Inc | 2.10% |
| 7 | BFLY | Butterfly Network Inc Ordinary Shares - Class A | 2.07% |
| 8 | LIVN | LivaNova PLC | 2.06% |
| 9 | OMCL | Omnicell Inc | 2.06% |
| 10 | TFX | Teleflex Inc | 2.00% |
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index ("S&P TMI").
Inception Date: 2011-01-26